MYO6 and breast neoplasm: Amongst these were 4 extensively studied splicing isoforms (MYO6, TPD52, IQCG, and ACOX2) [27] identified to be amongst the 5 most important isoforms differentially expressed between ER+HER2− and ER-HER2 primary breast tumors (Fig. S4).